ACI Formulations (DHA:ACIFORMULA) Cyclically Adjusted Revenue per Share: BDT109.97 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:ACIFORMULA ACI Formulations PLC DHA:ACIFORMULA
91 GF Score
Price BDT152.70
GF Value BDT150.73
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is ACI Formulations Cyclically Adjusted Revenue per Share?

ACI Formulations DHA:ACIFORMULA +3.11% 91 Cyclically Adjusted Revenue per Share is BDT109.97 as of Mar. 2026. GuruFocus rates DHA:ACIFORMULA with a GF Score™ of 91/100 and a GF Value™ of BDT150.73 (Fairly Valued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

ACI Formulations's adjusted revenue per share for the three months ended in Mar. 2026 was BDT28.744. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is BDT109.97 for the trailing ten years ended in Mar. 2026.

During the past 12 months, ACI Formulations's average Cyclically Adjusted Revenue Growth Rate was 6.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-09-10), ACI Formulations's current stock price is BDT152.70. ACI Formulations's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was BDT109.97. ACI Formulations's Cyclically Adjusted PS Ratio of today is 1.39.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of ACI Formulations was 1.73. The lowest was 1.11. And the median was 1.33.


ACI Formulations  (DHA:ACIFORMULA) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

ACI Formulations's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=152.70/109.97
=1.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of ACI Formulations was 1.73. The lowest was 1.11. And the median was 1.33.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


ACI Formulations Cyclically Adjusted Revenue per Share Related Terms


ACI Formulations Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for ACI Formulations's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ACI Formulations Cyclically Adjusted Revenue per Share Chart

ACI Formulations Annual Data
Trend Dec15 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 97.43 98.92 104.36

ACI Formulations Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 103.55 104.36 106.80 108.32 109.97

DHA:ACIFORMULA vs CTVA, CF, MOS: Cyclically Adjusted Revenue per Share Comparison

For the Agricultural Inputs subindustry, ACI Formulations's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ACI Formulations Cyclically Adjusted PS Ratio vs Agriculture Industry

For the Agriculture industry and Basic Materials sector, ACI Formulations's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where ACI Formulations's Cyclically Adjusted PS Ratio falls into.


DHA:ACIFORMULA
91GF Score
ACI Formulations PLC DHA:ACIFORMULA
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ACI Formulations Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, ACI Formulations's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=28.744/330.2130*330.2130
=28.744

Current CPI (Mar. 2026) = 330.2130.

ACI Formulations Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201603 20.662 238.132 28.652
201609 14.751 241.428 20.176
201612 25.739 241.432 35.204
201703 22.614 243.801 30.629
201706 14.421 244.955 19.440
201709 13.924 246.819 18.629
201712 27.453 246.524 36.773
201803 28.850 249.554 38.175
201806 17.353 251.989 22.740
201809 20.061 252.439 26.242
201812 25.827 251.233 33.946
201903 23.167 254.202 30.094
201906 16.622 256.143 21.429
201909 15.881 256.759 20.424
201912 19.083 256.974 24.522
202003 19.886 258.115 25.441
202006 17.445 257.797 22.345
202009 17.916 260.280 22.730
202012 22.622 260.474 28.679
202103 23.271 264.877 29.011
202106 17.935 271.696 21.798
202109 21.590 274.310 25.990
202112 26.893 278.802 31.852
202203 24.578 287.504 28.229
202206 16.828 296.311 18.753
202209 27.374 296.808 30.455
202212 30.427 296.797 33.853
202303 27.783 301.836 30.395
202306 19.542 305.109 21.150
202309 30.274 307.789 32.480
202312 29.365 306.746 31.612
202403 26.107 312.332 27.602
202406 18.709 314.175 19.664
202409 25.671 315.301 26.885
202412 34.085 315.605 35.663
202503 27.484 319.799 28.379
202506 22.239 322.561 22.767
202509 28.254 324.800 28.725
202512 38.731 324.054 39.467
202603 28.744 330.213 28.744

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of BDT109.97 mean?
ACI Formulations (DHA:ACIFORMULA) has a Cyclically Adjusted Revenue per Share of BDT109.97 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on ACI Formulations and its competitors.
Is ACI Formulations' Cyclically Adjusted Revenue per Share too high?
ACI Formulations' current Cyclically Adjusted Revenue per Share is BDT109.97. Overall, ACI Formulations has a GF Score™ of 91/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does ACI Formulations' Cyclically Adjusted Revenue per Share compare to CTVA and CF?
ACI Formulations' Cyclically Adjusted Revenue per Share of BDT109.97 can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for an Agriculture company?
A good Cyclically Adjusted Revenue per Share depends on the Agriculture industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on ACI Formulations and its competitors. ACI Formulations's current Cyclically Adjusted Revenue per Share is BDT109.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ACI Formulations stock overvalued right now?
Based on GuruFocus' analysis, ACI Formulations (DHA:ACIFORMULA) is currently considered Fairly Valued. The stock's GF Value™ is BDT150.73, compared to a current price of BDT152.70 — trading 1.3% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is BDT109.97. ACI Formulations' overall GF Score™ is 91/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For ACI Formulations (DHA:ACIFORMULA), the current Cyclically Adjusted Revenue per Share is BDT109.97 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ACI Formulations (DHA:ACIFORMULA) Overvalued in 2026?

Based on GuruFocus' analysis, ACI Formulations stock appears to be overvalued. The current stock price of BDT152.70 is trading 1.3% above its estimated GF Value™ of BDT150.73. GuruFocus considers ACI Formulations to be Fairly Valued.

Key valuation signals for DHA:ACIFORMULA:

  • Cyclically Adjusted Revenue per Share: BDT109.97
  • GF Value™: BDT150.73 vs. price of BDT152.70 (1.3% above fair value)
  • GF Score™: 91/100 with 4 warning signs

No single metric tells the full story. See the DHA:ACIFORMULA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ACI Formulations Business Description

Address ACI Centre, 245, Tejgaon Industrial Area, Dhaka, BGD, 1208
ACI Formulations PLC is engaged in the manufacturing and marketing of several agrochemical and consumer products. The company offers a complete range of cost-effective solutions for farmers through formulating and marketing insecticides, herbicides, fungicides, miticides, etc. Its businesses are Pharmaceuticals, Salt, Skincare & Antiseptics, Kitchen Care, Fabric Care, Surface Care, Herbal Care, Lavatory Care, and Others. The group's reportable segments are Crop Care and Public Health (CC & PH), which include manufacturing and selling crop care and public health products; Mosquito coil (M. Coil) includes manufacturing and selling mosquito coil products; Aerosol provides manufacturing and selling aerosol and air freshener products; and Paint covers manufacture and sell paint products.
91GF Score

Get the complete analysis for DHA:ACIFORMULA

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT152.70
Price
BDT150.73
GF Value